Study results demonstrate that statins have antitumor activity in various solid-tumor cancers and leukemia; however, experts offer these caveats on using them to treat cancer — at least for now.
Statins provide no benefits, or adverse effects, in patients with lung cancer, according to a phase 3 trial.
Statins could be an effective agent for the treatment of patients with metastatic small cell lung cancer.
New guidelines released by the American College of Cardiology (ACC) and the American Heart Association (AHA) would have 13 million more Americans taking the cholesterol drugs, experts say.
Statin use may slow prostate cancer progression in patients receiving androgen deprivation therapy, but more trials are needed to confirm benefits, researchers say.
The use of statins for a year before a diagnosis of lung cancer is associated with a lower risk of cancer-specific mortality, but more research is needed.
Risk reduction appears sex specific, with significant reduction seen for men, but not women.
Findings among men taking a statin alongside androgen deprivation therapy showed additional months of progression-free survival.
Low density lipoprotein (LDL), or "bad cholesterol," stays the same or increases after taking statin medications.
Clinical trials on the use of statins as an anticancer drug have yielded mixed results.
Use of statins is associated with a reduced risk of progression of localized renal cell carcinoma, according to research.
Sign Up for Free e-newsletters
- Resolving Vaginal Dryness in Women With a History of Breast Cancer
- FDA Issues Warning for Rolapitant Injectable Emulsion in the Treatment of CINV
- Risk Factors for Arterial, Venous Thrombosis Differ in Polycythemia Vera
- Distinct Patterns of Shiny White Streaks Strong Indicator of Melanoma
- Survival Outcomes in Relapsed Hepatocellular Carcinoma Improved With Cabozantinib
- Pertuzumab Regimen Approved for Adjuvant, Neoadjuvant Therapy in Specific Breast Cancers
- Common Oncologic Emergencies That Occur With Multiple Myeloma
- Artificial Sweeteners and Cancer Risk (Fact Sheet)
- Blueberry Extract May Boost Efficacy of Radiotherapy for Cervical Cancer
- Dietary Estrogens Reduced Efficacy of Novel Breast Cancer Therapy
- When There Are No Words: Interpreting Patients' and Families' Subtle Messages
- Depression Predictive of Poor Survival Outcomes in Head and Neck Cancer
- Nearly One Third of Veterans Report Current Tobacco Use
- Priority Review of New Drug Application Granted to Apalutamide for CRPC
- Partial Response Achieved With Atezolizumab, Cobimetinib in Pretreated CRC
Regimen and Drug Listings
GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION
|Head and Neck Cancer||Regimens||Drugs|